corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library item: 16263

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

 

Publication type: news

Carroll J
NIH chief may ask pharma to pay royalties on research
FierceBiotech Research 2009 Aug 18
http://www.fiercebiotechresearch.com/story/nih-chief-may-ask-pharma-pay-royalties-research/2009-08-18


Full text:

Looking past 2010, when more than $10 billion in fresh federal research funds runs out, the new head of the NIH is hatching a plan to gain a predictable flow of money to back an enlarged commitment to the country’s researchers. And one way that the NIH could gain extra financial support, Dr. Francis Collins suggests, is by claiming a royalty from drugs that are developed following federally-supported research efforts.
Dr. Collins says that the extra research money included in the federal stimulus bill attracted 22,000 grant proposals, which he sees as a clear sign of just how much demand there is for these funds. “There is fabulous science there. This tells you there is pent-up demand,” Collins told reporters.
Collins also outlined a vision he has to recruit 500,000 people for a long-term study that can identify the biologic triggers of disease. “I think if we don’t start a study of this sort in the next 10 years, we will be kicking ourselves.”

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.

Email a Friend








What these howls of outrage and hurt amount to is that the medical profession is distressed to find its high opinion of itself not shared by writers of [prescription] drug advertising. It would be a great step forward if doctors stopped bemoaning this attack on their professional maturity and began recognizing how thoroughly justified it is.
- Pierre R. Garai (advertising executive) 1963